{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T08:26:46Z","timestamp":1771489606117,"version":"3.50.1"},"reference-count":80,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","onlinecjc.ca","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Canadian Journal of Cardiology"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.cjca.2023.06.421","type":"journal-article","created":{"date-parts":[[2023,6,30]],"date-time":"2023-06-30T20:41:54Z","timestamp":1688157714000},"page":"1795-1807","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Recent Advances in Understanding the Molecular Pathophysiology of Angiotensin II Receptors: Lessons From Cell-Selective Receptor Deletion in Mice"],"prefix":"10.1016","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8407-7501","authenticated-orcid":false,"given":"Satoru","family":"Eguchi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew A.","family":"Sparks","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hisashi","family":"Sawada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong S.","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alan","family":"Daugherty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jia L.","family":"Zhuo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cjca.2023.06.421_bib1","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1152\/physrev.00038.2017","article-title":"Angiotensin II signal transduction: an update on mechanisms of physiology and pathophysiology","volume":"98","author":"Forrester","year":"2018","journal-title":"Physiol Rev"},{"key":"10.1016\/j.cjca.2023.06.421_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.mce.2021.111259","article-title":"Angiotensin receptors in the kidney and vasculature in hypertension and kidney disease","volume":"529","author":"Rianto","year":"2021","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.cjca.2023.06.421_bib3","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1161\/HYPERTENSIONAHA.118.10266","article-title":"Understanding angiotensin II type 1 receptor signaling in vascular pathophysiology","volume":"71","author":"Eguchi","year":"2018","journal-title":"Hypertension"},{"key":"10.1016\/j.cjca.2023.06.421_bib4","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1161\/ATVBAHA.121.317058","article-title":"Twenty years of studying Ang II (angiotensin II)-induced abdominal aortic pathologies in mice: continuing questions and challenges to provide insight into the human disease","volume":"42","author":"Sawada","year":"2022","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.cjca.2023.06.421_bib5","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1124\/pharmrev.120.000281","article-title":"The angiotensin AT(2) receptor: from a binding site to a novel therapeutic target","volume":"74","author":"Steckelings","year":"2022","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.cjca.2023.06.421_bib6","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.cmet.2011.03.001","article-title":"AT1A angiotensin receptors in the renal proximal tubule regulate blood pressure","volume":"13","author":"Gurley","year":"2011","journal-title":"Cell Metab"},{"key":"10.1016\/j.cjca.2023.06.421_bib7","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1161\/CIRCRESAHA.110.222844","article-title":"Endothelial cell-specific deficiency of Ang II type 1a receptors attenuates Ang II-induced ascending aortic aneurysms in LDL receptor\u2013\/\u2013 mice","volume":"108","author":"Rateri","year":"2011","journal-title":"Circ Res"},{"key":"10.1016\/j.cjca.2023.06.421_bib8","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1172\/JCI115881","article-title":"Vascular smooth muscle cell hypertrophy vs. hyperplasia. Autocrine transforming growth factor-beta 1 expression determines growth response to angiotensin II","volume":"90","author":"Gibbons","year":"1992","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.cjca.2023.06.421_bib9","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1161\/HYPERTENSIONAHA.110.165274","article-title":"Angiotensin II type 1A receptors in vascular smooth muscle cells do not influence aortic remodeling in hypertension","volume":"57","author":"Sparks","year":"2011","journal-title":"Hypertension"},{"key":"10.1016\/j.cjca.2023.06.421_bib10","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1161\/ATVBAHA.115.305995","article-title":"Fibroblast aAngiotensin II type 1a receptors contribute to angiotensin II-induced medial hyperplasia in the ascending aorta","volume":"35","author":"Poduri","year":"2015","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.cjca.2023.06.421_bib11","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1126\/science.1082095","article-title":"LRP: role in vascular wall integrity and protection from atherosclerosis","volume":"300","author":"Boucher","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.cjca.2023.06.421_bib12","doi-asserted-by":"crossref","first-page":"3062","DOI":"10.1161\/01.CIR.0000137970.47771.AF","article-title":"Inhibition of diet-induced atherosclerosis and endothelial dysfunction in apolipoprotein E\/angiotensin II type 1A receptor double-knockout mice","volume":"110","author":"Wassmann","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2023.06.421_bib13","doi-asserted-by":"crossref","first-page":"3849","DOI":"10.1161\/01.CIR.0000150540.54220.C4","article-title":"Hypercholesterolemia stimulates angiotensin peptide synthesis and contributes to atherosclerosis through the AT1A receptor","volume":"110","author":"Daugherty","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2023.06.421_bib14","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0051483","article-title":"Depletion of endothelial or smooth muscle cell-specific angiotensin II type 1a receptors does not influence aortic aneurysms or atherosclerosis in LDL receptor deficient mice","volume":"7","author":"Rateri","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.cjca.2023.06.421_bib15","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1172\/JCI7818","article-title":"Angiotensin II promotes atherosclerotic lesions and aneurysms in apolipoprotein E-deficient mice","volume":"105","author":"Daugherty","year":"2000","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.cjca.2023.06.421_bib16","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1161\/ATVBAHA.115.307038","article-title":"Angiotensin-converting enzyme in smooth muscle cells promotes atherosclerosis-brief report","volume":"36","author":"Chen","year":"2016","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.cjca.2023.06.421_bib17","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1253\/circj.CJ-19-0955","article-title":"Angiotensin I infusion reveals differential effects of angiotensin-converting enzyme in aortic resident cells on aneurysm formation","volume":"84","author":"Sawada","year":"2020","journal-title":"Circ J"},{"key":"10.1016\/j.cjca.2023.06.421_bib18","doi-asserted-by":"crossref","first-page":"e23","DOI":"10.1161\/01.ATV.0000202661.61837.93","article-title":"Generation of an adult smooth muscle cell-targeted Cre recombinase mouse model","volume":"26","author":"Zhang","year":"2006","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.cjca.2023.06.421_bib19","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1172\/JCI32503","article-title":"An antiproliferative BMP-2\/PPARgamma\/apoE axis in human and murine SMCs and its role in pulmonary hypertension","volume":"118","author":"Hansmann","year":"2008","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.cjca.2023.06.421_bib20","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1161\/CIRCULATIONAHA.108.815803","article-title":"Vascular smooth muscle cell-selective peroxisome proliferator-activated receptor-gamma deletion leads to hypotension","volume":"119","author":"Chang","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2023.06.421_bib21","doi-asserted-by":"crossref","first-page":"2953","DOI":"10.1681\/ASN.2014080816","article-title":"Vascular type 1A angiotensin II receptors control BP by regulating renal blood flow and urinary sodium excretion","volume":"26","author":"Sparks","year":"2015","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.cjca.2023.06.421_bib22","doi-asserted-by":"crossref","first-page":"F997","DOI":"10.1152\/ajprenal.00639.2017","article-title":"Vascular type 1 angiotensin receptors control blood pressure by augmenting peripheral vascular resistance in female mice","volume":"315","author":"Wolf","year":"2018","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.cjca.2023.06.421_bib23","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1161\/HYPERTENSIONAHA.122.20601","article-title":"Angiotensin II type 1A receptor expressed in smooth muscle cells is required for hypertensive vascular remodeling in mice infused with angiotensin II","volume":"80","author":"Okuno","year":"2023","journal-title":"Hypertension"},{"key":"10.1016\/j.cjca.2023.06.421_bib24","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1161\/HYPERTENSIONAHA.109.140558","article-title":"Pharmacologically induced thoracic and abdominal aortic aneurysms in mice","volume":"55","author":"Kanematsu","year":"2010","journal-title":"Hypertension"},{"key":"10.1016\/j.cjca.2023.06.421_bib25","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.yjmcc.2023.01.013","article-title":"Smooth muscle angiotensin II type 1A receptor is required for abdominal aortic aneurysm formation induced by angiotensin II plus beta-aminopropionitrile","volume":"176","author":"Okuno","year":"2023","journal-title":"J\u00a0Mol Cell Cardiol"},{"key":"10.1016\/j.cjca.2023.06.421_bib26","doi-asserted-by":"crossref","first-page":"H1660","DOI":"10.1152\/ajpheart.00028.2009","article-title":"ANG II infusion promotes abdominal aortic aneurysms independent of increased blood pressure in hypercholesterolemic mice","volume":"296","author":"Cassis","year":"2009","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.cjca.2023.06.421_bib27","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1161\/HYPERTENSIONAHA.116.07620","article-title":"Vascular ADAM17 as a novel therapeutic target in mediating cardiovascular hypertrophy and perivascular fibrosis induced by angiotensin II","volume":"68","author":"Takayanagi","year":"2016","journal-title":"Hypertension"},{"key":"10.1016\/j.cjca.2023.06.421_bib28","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1161\/HYPERTENSIONAHA.117.09822","article-title":"Vascular ADAM17 (a disintegrin and metalloproteinase domain 17) is required for angiotensin II\/beta-aminopropionitrile-induced abdominal aortic aneurysm","volume":"70","author":"Kawai","year":"2017","journal-title":"Hypertension"},{"key":"10.1016\/j.cjca.2023.06.421_bib29","article-title":"Myogenic vasoconstriction requires canonical G(q\/11) signaling of the angiotensin II type 1 receptor","volume":"11","author":"Cui","year":"2022","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.cjca.2023.06.421_bib30","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1161\/ATVBAHA.119.312449","article-title":"Promoters to study vascular smooth muscle","volume":"39","author":"Chakraborty","year":"2019","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.cjca.2023.06.421_bib31","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1161\/HYPERTENSIONAHA.119.14079","article-title":"Direct actions of AT1 (type 1 angiotensin) receptors in cardiomyocytes do not contribute to cardiac hypertrophy","volume":"77","author":"Sparks","year":"2021","journal-title":"Hypertension"},{"key":"10.1016\/j.cjca.2023.06.421_bib32","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1161\/HYPERTENSIONAHA.113.01474","article-title":"Stimulation of angiotensin type 1A receptors on catecholaminergic cells contributes to angiotensin-dependent hypertension","volume":"62","author":"Jancovski","year":"2013","journal-title":"Hypertension"},{"key":"10.1016\/j.cjca.2023.06.421_bib33","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1161\/HYPERTENSIONAHA.120.16336","article-title":"Proximal tubule-specific deletion of angiotensin II type 1a receptors in the kidney attenuates circulating and intratubular angiotensin II-induced hypertension in PT-Agtr1a(\u2013\/\u2013) mice","volume":"77","author":"Li","year":"2021","journal-title":"Hypertension"},{"key":"10.1016\/j.cjca.2023.06.421_bib34","doi-asserted-by":"crossref","first-page":"F1031","DOI":"10.1152\/ajprenal.00024.2013","article-title":"Protective role of the endothelial isoform of nitric oxide synthase in ANG II-induced inflammatory responses in the kidney","volume":"305","author":"Whiting","year":"2013","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.cjca.2023.06.421_bib35","doi-asserted-by":"crossref","first-page":"19087","DOI":"10.1073\/pnas.0602715103","article-title":"Angiotensinergic stimulation of vascular endothelium in mice causes hypotension, bradycardia, and attenuated angiotensin response","volume":"103","author":"Ramchandran","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.cjca.2023.06.421_bib36","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1161\/01.ATV.0000254680.71485.92","article-title":"Bone marrow transplantation reveals that recipient AT1a receptors are required to initiate angiotensin II-induced atherosclerosis and aneurysms","volume":"27","author":"Cassis","year":"2007","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.cjca.2023.06.421_bib37","doi-asserted-by":"crossref","first-page":"3819","DOI":"10.1073\/pnas.96.7.3819","article-title":"Pathogenetic sequence for aneurysm revealed in mice underexpressing fibrillin-1","volume":"96","author":"Pereira","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.cjca.2023.06.421_bib38","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1161\/ATVBAHA.117.310609","article-title":"Cell type-specific contributions of the angiotensin II type 1a receptor to aorta homeostasis and aneurysmal disease-brief report","volume":"38","author":"Galatioto","year":"2018","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.cjca.2023.06.421_bib39","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1161\/ATVBAHA.117.309599","article-title":"Smooth muscle cells derived from second heart field and cardiac neural crest reside in spatially distinct domains in the media of the ascending aorta-brief report","volume":"37","author":"Sawada","year":"2017","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.cjca.2023.06.421_bib40","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2022.936142","article-title":"Distinct contribution of global and regional angiotensin II type 1a receptor inactivation to amelioration of aortopathy in Tgfbr1 (M318R\/+) mice","volume":"9","author":"Bramel","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.cjca.2023.06.421_bib41","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1161\/HYPERTENSIONAHA.111.00356","article-title":"Angiotensin type 1a receptors in the subfornical organ are required for deoxycorticosterone acetate-salt hypertension","volume":"61","author":"Hilzendeger","year":"2013","journal-title":"Hypertension"},{"key":"10.1016\/j.cjca.2023.06.421_bib42","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1161\/CIRCRESAHA.116.310509","article-title":"Clinical relevance and role of neuronal AT(1) receptors in ADAM17-mediated ACE2 shedding in neurogenic hypertension","volume":"121","author":"Xu","year":"2017","journal-title":"Circ Res"},{"key":"10.1016\/j.cjca.2023.06.421_bib43","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1172\/JCI23378","article-title":"Distinct roles for the kidney and systemic tissues in blood pressure regulation by the renin-angiotensin system","volume":"115","author":"Crowley","year":"2005","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.cjca.2023.06.421_bib44","doi-asserted-by":"crossref","first-page":"R1067","DOI":"10.1152\/ajpregu.00124.2011","article-title":"Renal proximal tubule angiotensin AT1A receptors regulate blood pressure","volume":"301","author":"Li","year":"2011","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"10.1016\/j.cjca.2023.06.421_bib45","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1042\/CS20201574","article-title":"Sex differences in angiotensin II-induced hypertension and kidney injury: role of AT1a receptors in the proximal tubule of the kidney","volume":"135","author":"Leite","year":"2021","journal-title":"Clin Sci (Lond)"},{"key":"10.1016\/j.cjca.2023.06.421_bib46","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232415798","article-title":"Genetic deletion of AT(1a) receptor or Na(+)\/H(+) exchanger 3 selectively in the proximal tubules of the kidney attenuates two-kidney, one-clip goldblatt hypertension in mice","volume":"23","author":"Li","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.cjca.2023.06.421_bib47","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1097\/01.ASN.0000133023.89251.01","article-title":"Specific Cre\/Lox recombination in the mouse proximal tubule","volume":"15","author":"Rubera","year":"2004","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.cjca.2023.06.421_bib48","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1681\/ASN.2010101095","article-title":"AT1 receptors in the collecting duct directly modulate the concentration of urine","volume":"22","author":"Stegbauer","year":"2011","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.cjca.2023.06.421_bib49","doi-asserted-by":"crossref","first-page":"F75","DOI":"10.1152\/ajprenal.2000.278.1.F75","article-title":"Abnormal water metabolism in mice lacking the type 1A receptor for ANG II","volume":"278","author":"Oliverio","year":"2000","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.cjca.2023.06.421_bib50","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/ki.2009.134","article-title":"AT1a receptor knockout in mice impairs urine concentration by reducing basal vasopressin levels and its receptor signaling proteins in the inner medulla","volume":"76","author":"Li","year":"2009","journal-title":"Kidney Int"},{"key":"10.1016\/j.cjca.2023.06.421_bib51","doi-asserted-by":"crossref","first-page":"F746","DOI":"10.1152\/ajprenal.00644.2011","article-title":"AT1a receptor signaling is required for basal and water deprivation-induced urine concentration in AT1a receptor-deficient mice","volume":"303","author":"Li","year":"2012","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.cjca.2023.06.421_bib52","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.92720","article-title":"Resistance to hypertension mediated by intercalated cells of the collecting duct","volume":"2","author":"Stegbauer","year":"2017","journal-title":"JCI Insight"},{"key":"10.1016\/j.cjca.2023.06.421_bib53","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1161\/HYPERTENSIONAHA.115.06987","article-title":"Impact of angiotensin type 1A receptors in principal cells of the collecting duct on blood pressure and hypertension","volume":"67","author":"Chen","year":"2016","journal-title":"Hypertension"},{"key":"10.1016\/j.cjca.2023.06.421_bib54","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1007\/s10571-012-9862-y","article-title":"Six commercially available angiotensin II AT1 receptor antibodies are non-specific","volume":"32","author":"Benicky","year":"2012","journal-title":"Cell Mol Neurobiol"},{"key":"10.1016\/j.cjca.2023.06.421_bib55","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1161\/HYPERTENSIONAHA.112.203679","article-title":"Lack of specificity of commercial antibodies leads to misidentification of angiotensin type 1 receptor protein","volume":"61","author":"Herrera","year":"2013","journal-title":"Hypertension"},{"key":"10.1016\/j.cjca.2023.06.421_bib56","doi-asserted-by":"crossref","first-page":"e31","DOI":"10.1161\/HYPERTENSIONAHA.111.00943","article-title":"Lack of specificity of commercial antibodies leads to misidentification of angiotensin type-1 receptor protein","volume":"61","author":"Elliott","year":"2013","journal-title":"Hypertension"},{"key":"10.1016\/j.cjca.2023.06.421_bib57","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1007\/s00210-018-1522-4","article-title":"No answer to the lack of specificity: mouse monoclonal antibody targeting the angiotensin II type 1 receptor AT(1) fails to recognize its target","volume":"391","author":"Bouressam","year":"2018","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"10.1016\/j.cjca.2023.06.421_bib58","doi-asserted-by":"crossref","first-page":"F1191","DOI":"10.1152\/ajprenal.00305.2018","article-title":"Apparently normal kidney development in mice with conditional disruption of ANG II-AT(1) receptor genes in FoxD1-positive stroma cell precursors","volume":"316","author":"Schrankl","year":"2019","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.cjca.2023.06.421_bib59","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1084\/jem.20070657","article-title":"Role of the T cell in the genesis of angiotensin II induced hypertension and vascular dysfunction","volume":"204","author":"Guzik","year":"2007","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.cjca.2023.06.421_bib60","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1161\/CIRCRESAHA.111.261768","article-title":"A\u00a0novel role for type 1 angiotensin receptors on T lymphocytes to limit target organ damage in hypertension","volume":"110","author":"Zhang","year":"2012","journal-title":"Circ Res"},{"key":"10.1016\/j.cjca.2023.06.421_bib61","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/j.ajpath.2019.02.004","article-title":"Stimulating type 1 angiotensin receptors on T lymphocytes attenuates renal fibrosis","volume":"189","author":"Wen","year":"2019","journal-title":"Am J Pathol"},{"key":"10.1016\/j.cjca.2023.06.421_bib62","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1161\/HYPERTENSIONAHA.121.18734","article-title":"Type 1 angiotensin receptors on CD11c-expressing cells protect against hypertension by regulating dendritic cell-mediated T cell activation","volume":"79","author":"Lu","year":"2022","journal-title":"Hypertension"},{"key":"10.1016\/j.cjca.2023.06.421_bib63","doi-asserted-by":"crossref","first-page":"2198","DOI":"10.1172\/JCI61368","article-title":"Type 1 angiotensin receptors on macrophages ameliorate IL-1 receptor-mediated kidney fibrosis","volume":"124","author":"Zhang","year":"2014","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.cjca.2023.06.421_bib64","article-title":"Myeloid angiotensin II type 1 receptor mediates macrophage polarization and promotes vascular injury in DOCA\/salt hypertensive mice","volume":"13","author":"Yang","year":"2022","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.cjca.2023.06.421_bib65","doi-asserted-by":"crossref","first-page":"R25","DOI":"10.1172\/JCI10037","article-title":"Evidence for angiotensin II type 2 receptor-mediated cardiac myocyte enlargement during in\u00a0vivo pressure overload","volume":"106","author":"Senbonmatsu","year":"2000","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.cjca.2023.06.421_bib66","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1161\/01.CIR.104.3.346","article-title":"Angiotensin II type 2 receptor is essential for left ventricular hypertrophy and cardiac fibrosis in chronic angiotensin II-induced hypertension","volume":"104","author":"Ichihara","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2023.06.421_bib67","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1161\/01.HYP.0000193504.51489.cf","article-title":"The angiotensin II type 2 receptor causes constitutive growth of cardiomyocytes and does not antagonize angiotensin II type 1 receptor-mediated hypertrophy","volume":"46","author":"D\u2019Amore","year":"2005","journal-title":"Hypertension"},{"key":"10.1016\/j.cjca.2023.06.421_bib68","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2021.782138","article-title":"Loss of angiotensin II type 2 receptor improves blood pressure in elastin insufficiency","volume":"8","author":"Lin","year":"2021","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.cjca.2023.06.421_bib69","doi-asserted-by":"crossref","first-page":"6506","DOI":"10.1073\/pnas.96.11.6506","article-title":"Sustained hypersensitivity to angiotensin II and its mechanism in mice lacking the subtype-2 (AT2) angiotensin receptor","volume":"96","author":"Siragy","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.cjca.2023.06.421_bib70","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1006\/bbrc.1999.1027","article-title":"Increased vasoconstrictor response of the mouse lacking angiotensin II type 2 receptor","volume":"261","author":"Akishita","year":"1999","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.cjca.2023.06.421_bib71","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1006\/bbrc.1999.0500","article-title":"Vascular response to angiotensin II is exaggerated through an upregulation of AT1 receptor in AT2 knockout mice","volume":"258","author":"Tanaka","year":"1999","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.cjca.2023.06.421_bib72","first-page":"91","article-title":"Update on angiotensin AT2 receptors","volume":"26","author":"Carey","year":"2017","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"10.1016\/j.cjca.2023.06.421_bib73","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1038\/377748a0","article-title":"Effects on blood pressure and exploratory behaviour of mice lacking angiotensin II type-2 receptor","volume":"377","author":"Ichiki","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.cjca.2023.06.421_bib74","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1038\/377744a0","article-title":"Behavioural and cardiovascular effects of disrupting the angiotensin II type-2 receptor in mice","volume":"377","author":"Hein","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.cjca.2023.06.421_bib75","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1161\/CIRCULATIONAHA.104.525550","article-title":"Deletion of angiotensin II type 2 receptor exaggerated atherosclerosis in apolipoprotein E-null mice","volume":"112","author":"Iwai","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2023.06.421_bib76","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0061849","article-title":"PD123319 augments angiotensin II-induced abdominal aortic aneurysms through an AT2 receptor-independent mechanism","volume":"8","author":"Daugherty","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.cjca.2023.06.421_bib77","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1126\/science.1192152","article-title":"Angiotensin II type 2 receptor signaling attenuates aortic aneurysm in mice through ERK antagonism","volume":"332","author":"Habashi","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.cjca.2023.06.421_bib78","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/3981790","article-title":"Central infusion of angiotensin II type 2 receptor agonist compound 21 attenuates DOCA\/NaCl-induced hypertension in female rats","volume":"2016","author":"Dai","year":"2016","journal-title":"Oxid Med Cell Longev"},{"key":"10.1016\/j.cjca.2023.06.421_bib79","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1093\/cvr\/cvab085","article-title":"Targeting angiotensin type-2 receptors located on pressor neurons in the nucleus of the solitary tract to relieve hypertension in mice","volume":"118","author":"Mohammed","year":"2022","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.cjca.2023.06.421_bib80","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1124\/pr.112.007278","article-title":"A\u00a0systematic comparison of the properties of clinically used angiotensin II type 1 receptor antagonists","volume":"65","author":"Michel","year":"2013","journal-title":"Pharmacol Rev"}],"container-title":["Canadian Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0828282X23014514?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0828282X23014514?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T14:55:45Z","timestamp":1760108145000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0828282X23014514"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":80,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["S0828282X23014514"],"URL":"https:\/\/doi.org\/10.1016\/j.cjca.2023.06.421","relation":{},"ISSN":["0828-282X"],"issn-type":[{"value":"0828-282X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Recent Advances in Understanding the Molecular Pathophysiology of Angiotensin II Receptors: Lessons From Cell-Selective Receptor Deletion in Mice","name":"articletitle","label":"Article Title"},{"value":"Canadian Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cjca.2023.06.421","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Canadian Cardiovascular Society. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}